TORRENT PHARMACEUTICALS L Intrinsic Value
TORNTPHARM · Healthcare · Current price ₹4,763
Is TORRENT PHARMACEUTICALS L undervalued?
DocStoX estimates the fair value of TORRENT PHARMACEUTICALS L at ₹932 per share, versus the current market price of ₹4,763. That puts the stock about -80.4% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹381), Relative P/E (₹2,219), Graham floor (₹597). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹381 (bear) to ₹932 (base) to ₹2,219 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹4,763 versus an intrinsic value of ₹932, TORRENT PHARMACEUTICALS L currently offers -80.4% of negative margin (i.e. a premium).
More on TORRENT PHARMACEUTICALS L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.